BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38436188)

  • 1. Factors affecting survival in patients undergoing percutaneous transhepatic biliary drainage for malignant biliary obstruction.
    Duzkopru Y; Eren T; Kocanoglu A; Dogan O; Isak OA; Ergun O
    Eur Rev Med Pharmacol Sci; 2024 Feb; 28(4):1554-1561. PubMed ID: 38436188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifactorial analysis of biliary infection after percutaneous transhepatic biliary drainage treatment of malignant biliary obstruction.
    Yu H; Yuanyuan S; Guo Z; Xing W; Si T; Guo X; Liu F
    J Cancer Res Ther; 2018; 14(7):1503-1508. PubMed ID: 30589030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing the Safety and Efficacy of Intraluminal Brachytherapy vs Isolated Percutaneous Transhepatic Biliary Drainage with internalization for Unresectable Malignant Biliary Obstruction: A Prospective Observational Study.
    Sood S; Alexander JV; Gupta M; Chauhan A
    Hematol Oncol Stem Cell Ther; 2023 Jul; 17(1):21-28. PubMed ID: 37581465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Nutritional Index (PNI) and Neutrophil to Lymphocyte Ratio (NLR) as Predictors of Short-Term Survival in Patients with Advanced Malignant Biliary Obstruction Treated with Percutaneous Transhepatic Biliary Drainage.
    Zakosek M; Bulatovic D; Pavlovic V; Filipovic A; Igic A; Galun D; Jovanovic D; Sisevic J; Masulovic D
    J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage PTBD With Chemotherapy Improves Survival in Patients With Unresectable Malignant Biliary Obstruction - A Single Center Retrospective Study.
    Muroya D; Tsuru H; Shimokobe H; Nagao Y; Yoshimoto Y; Wada Y; Hayashi K; Taniwaki S; Midorikawa R; Taniwaki S; Kojima S; Arai S; Shirahama T; Goto Y; Sakai H; Yoshitomi M; Hisaka T; Akagi Y; Okuda K
    Anticancer Res; 2022 Aug; 42(8):4063-4070. PubMed ID: 35896223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between functional drainage and survival in malignant biliary obstruction after percutaneous biliary drainage.
    Yang H; Qin Q; Tang Y; Zhu W
    Heliyon; 2024 Jan; 10(2):e24088. PubMed ID: 38293534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of the comparison of the incidence of seeding metastasis between endoscopic biliary drainage and percutaneous transhepatic biliary drainage for resectable malignant biliary obstruction.
    Wang L; Lin N; Xin F; Ke Q; Zeng Y; Liu J
    World J Surg Oncol; 2019 Jul; 17(1):116. PubMed ID: 31277666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and predictive factors in cancer patients with obstructive jaundice treated by percutaneous transhepatic biliary drainage: A single-center experience.
    Sahinli H; Özet A
    J Cancer Res Ther; 2020 Dec; 16(Supplement):S99-S103. PubMed ID: 33380661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the efficacy of initial percutaneous transhepatic biliary drainage and endoscopic retrograde cholangiopancreatography with stenting for relief of biliary obstruction in unresectable cholangiocarcinoma.
    O'Brien S; Bhutiani N; Egger ME; Brown AN; Weaver KH; Kline D; Kelly LR; Scoggins CR; Martin RCG; Vitale GC
    Surg Endosc; 2020 Mar; 34(3):1186-1190. PubMed ID: 31139984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous transhepatic biliary drainage in patients with advanced solid malignancies: prognostic factors and clinical outcomes.
    Crosara Teixeira M; Mak MP; Marques DF; Capareli F; Carnevale FC; Moreira AM; Ribeiro U; Cecconello I; Hoff PM
    J Gastrointest Cancer; 2013 Dec; 44(4):398-403. PubMed ID: 23760941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion of percutaneous transhepatic biliary drainage to endoscopic ultrasound-guided biliary drainage.
    Morita S; Sugawara S; Suda T; Hoshi T; Abe S; Yagi K; Terai S
    DEN Open; 2021 Apr; 1(1):e6. PubMed ID: 35310153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Clinical Benefit of Percutaneous Transhepatic Biliary Drainage for Malignant Biliary Tract Obstruction.
    Nikolić I; Radić J; Petreš A; Djurić A; Protić M; Litavski J; Popović M; Kolarov-Bjelobrk I; Dragin S; Popović L
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The outcomes of biliary drainage by percutaneous transhepatic cholangiography for the palliation of malignant biliary obstruction in England between 2001 and 2014: a retrospective cohort study.
    Rees J; Mytton J; Evison F; Mangat KS; Patel P; Trudgill N
    BMJ Open; 2020 Jan; 10(1):e033576. PubMed ID: 31980509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes after percutaneous biliary interventions in patients with malignant biliary obstruction caused by metastatic gastric cancer.
    Gwon DI; Ko GY; Sung KB; Yoon HK; Kim KA; Kim YJ; Kim TH; Lee WH
    Acta Radiol; 2012 May; 53(4):422-9. PubMed ID: 22403081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EUS-guided biliary drainage with electrocautery-enhanced lumen-apposing metal stent placement should replace PTBD after ERCP failure in patients with distal tumoral biliary obstruction: a large real-life study.
    Ginestet C; Sanglier F; Hummel V; Rouchaud A; Legros R; Lepetit H; Dahan M; Carrier P; Loustaud-Ratti V; Sautereau D; Albouys J; Jacques J; Geyl S
    Surg Endosc; 2022 May; 36(5):3365-3373. PubMed ID: 34606007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of cholangitis on survival of patients with malignant biliary obstruction treated with percutaneous transhepatic biliary drainage.
    Niemelä J; Kallio R; Ohtonen P; Saarnio J; Syrjälä H
    BMC Gastroenterol; 2023 Mar; 23(1):91. PubMed ID: 36973653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten years single center experience in percutaneous transhepatic decompression of biliary tree in patients with malignant obstructive jaundice.
    Garcarek J; Kurcz J; Guziński M; Janczak D; Sasiadek M
    Adv Clin Exp Med; 2012; 21(5):621-32. PubMed ID: 23356199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome of malignant biliary obstruction caused by metastatic gastric cancer.
    Migita K; Watanabe A; Yoshioka T; Kinoshita S; Ohyama T
    World J Surg; 2009 Nov; 33(11):2396-402. PubMed ID: 19655195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival benefit of percutaneous transhepatic biliary drainage for malignant biliary tract obstruction-a prospective study comparing external and internal drainage techniques.
    Kumar S; Singh P; Kumar V; Kumar M; Mahto M
    Abdom Radiol (NY); 2021 Nov; 46(11):5408-5416. PubMed ID: 34292362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of high-dose-rate intraluminal brachytherapy by percutaneous transhepatic biliary drainage in the palliative management of malignant biliary obstruction--a pilot study.
    Aggarwal R; Patel FD; Kapoor R; Kang M; Kumar P; Chander Sharma S
    Brachytherapy; 2013; 12(2):162-70. PubMed ID: 23186613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.